diltiazem has been researched along with Drug Withdrawal Symptoms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (25.93) | 18.7374 |
| 1990's | 17 (62.96) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin Guise, J; Bickel, W; Brooks Gentry, W; Cargile, C; Mancino, M; Oliveto, A; Sanders, N | 1 |
| Al-Zaiti, SS; Carey, MG; Kozik, TM; Pelter, M | 1 |
| Hayashida, S; Honda, T; Katsura, M; Ohkuma, S; Torigoe, F; Tsujimura, A | 1 |
| Bowles, MJ; Davies, AB; Khurmi, NS; O'Hara, MJ; Raftery, EB; Subramanian, VB | 1 |
| Baeyens, JM; Barrios, M; Robles, I | 1 |
| Feng, Y; Ho, IK; Tokuyama, S; Wakabayashi, H | 1 |
| Alfaro, MJ; Colado, MI; Del Val, V; Lopez, F; Martin, MI | 1 |
| Little, HJ; Watson, WP | 1 |
| Deckert, J; Gleiter, CH; Przuntek, H | 1 |
| Misawa, M; Mizoguchi, H; Noguchi, H; Suzuki, T; Yoshii, T | 1 |
| Ho, IK; Tokuyama, S | 2 |
| Fukunaga, Y; Inoue, N; Kishioka, S; Nishida, S; Yamamoto, H | 1 |
| Attia, AS; Khayyal, MT; Saad, ES; Saad, SF | 1 |
| Bailey, CP; Little, HJ; Molleman, A | 1 |
| Kelly, WN; Mertl, SY | 1 |
| Grossman, E; Maoz, E; Rosenthal, T; Thaler, M | 1 |
| Reynen, M; Yutrzenka, GJ | 1 |
| Eichelman, B; Pucilowski, O | 1 |
| Baeyens, JM; Barrios, M | 2 |
| Alfaro, MJ; Colado, MI; López, F; Martín, MI | 1 |
| Slagle, DA | 1 |
| Bala Subramanian, V | 1 |
| Evreux, JC; Fournier, G; Levrat, R; Vital Durand, D | 1 |
| Caldwell, EG; Flicker, MR; Quigley, MA | 1 |
| Bansal, VK; Dixon, DW; Hano, JE; Hurley, RM; Kozeny, GA; Ragona, BP; Vertuno, LL | 1 |
1 trial(s) available for diltiazem and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Self Report; Substance Withdrawal Syndrome; Verapamil | 2013 |
26 other study(ies) available for diltiazem and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Holiday heart syndrome.
Topics: Acute Disease; Alcohol-Related Disorders; Atrial Fibrillation; Cardiovascular Agents; Diltiazem; Echocardiography; Electric Countershock; Holidays; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 2014 |
Ethanol physical dependence is accompanied by up-regulated expression of L-type high voltage-gated calcium channel alpha1 subunits in mouse brain.
Topics: Administration, Inhalation; Alcoholism; Animals; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Diltiazem; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Male; Mice; Nifedipine; Pyrazoles; Substance Withdrawal Syndrome; Up-Regulation | 2005 |
Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring.
Topics: Aged; Angina Pectoris; Calcium; Diltiazem; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Substance Withdrawal Syndrome; Verapamil | 1983 |
Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Animal; Calcium Channels; Clonidine; Diltiazem; Dose-Response Relationship, Drug; Drug Implants; Female; Ileum; In Vitro Techniques; Isomerism; Mice; Muscle Contraction; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Verapamil; Yohimbine | 1993 |
Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Opioid-Related Disorders; Pons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Animal; Brain Chemistry; Clonidine; Diltiazem; Hydroxyindoleacetic Acid; Male; Morphine Dependence; Naloxone; Nimodipine; Rats; Rats, Sprague-Dawley; Serotonin; Spinal Cord; Substance Withdrawal Syndrome | 1993 |
Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.
Topics: Anesthesia, General; Animals; Ataxia; Behavior, Animal; Body Temperature; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Drug Interactions; Ethanol; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Motor Activity; Postural Balance; Spasm; Substance Withdrawal Syndrome; Tremor | 1994 |
Organic anxiety syndrome after withdrawal of atenolol.
Topics: Aged; Anxiety Disorders; Atenolol; Diltiazem; Humans; Hypertension; Lorazepam; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Effects of flunarizine and diltiazem on physical dependence on barbital in rats.
Topics: Animals; Barbital; Calcium Channel Blockers; Calcium Channels; Diltiazem; Flunarizine; Male; Postural Balance; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders; Weight Loss | 1993 |
Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Topics: Animals; Brain; Butorphanol; Calcium Channel Blockers; Cerebral Cortex; Corpus Striatum; Diltiazem; Dopamine; Male; Mesencephalon; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats.
Topics: Animals; Body Weight; Calcium Channel Blockers; Corticosterone; Diarrhea; Diltiazem; Drug Interactions; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Influence of certain calcium-channel blockers on some aspects of lorazepam-dependence in mice.
Topics: Animals; Brain Chemistry; Calcium Channel Blockers; Diltiazem; Dopamine; Flunarizine; Isradipine; Lorazepam; Male; Mice; Norepinephrine; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption.
Topics: Acetates; Alcoholism; Amines; Animals; Behavior, Animal; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diltiazem; Ethanol; Felodipine; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Isradipine; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Substance Withdrawal Syndrome | 1998 |
Calcium-channel blocker withdrawal in a pregnant woman.
Topics: Adult; Aged; Animals; Calcium Channel Blockers; Cholecystitis; Coronary Vasospasm; Diltiazem; Female; Gallbladder; Humans; Male; Medical Errors; Middle Aged; Pregnancy; Substance Withdrawal Syndrome; Substance-Related Disorders | 1999 |
Carbamazepine neurotoxic reaction after administration of diltiazem.
Topics: Carbamazepine; Diltiazem; Drug Interactions; Epilepsy; Female; Humans; Hypertension; Middle Aged; Nervous System Diseases; Substance Withdrawal Syndrome | 1992 |
Diltiazem alters some withdrawal signs in pentobarbital-dependent rats.
Topics: Animals; Calcium Channels; Diltiazem; Drug Synergism; Male; Pentobarbital; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1991 |
Diltiazem suppresses quinpirole-induced oral stereotypies in haloperidol withdrawn rats.
Topics: Analysis of Variance; Animals; Diltiazem; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance Withdrawal Syndrome | 1991 |
Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Female; Mice; Morphine Dependence; Naloxone; Nicardipine; Postural Balance; Substance Withdrawal Syndrome; Verapamil | 1991 |
Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum.
Topics: Animals; Clonidine; Diltiazem; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Morphine Dependence; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Naloxone; Nimodipine; Substance Withdrawal Syndrome | 1990 |
Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Diltiazem; Ethanol; Female; In Vitro Techniques; Morphine; Muscle Contraction; Muscle, Smooth, Vascular; Naloxone; Rats; Rats, Inbred Strains; Stereoisomerism; Substance Withdrawal Syndrome; Verapamil | 1988 |
The acute withdrawal of diltiazem and atenolol: a possible challenge to affective stability.
Topics: Adult; Angina Pectoris; Atenolol; Atrial Flutter; Bipolar Disorder; Diltiazem; Female; Humans; Hypertension; Substance Withdrawal Syndrome | 1989 |
Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Coronary Circulation; Coronary Disease; Diltiazem; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Contraction; Nifedipine; Substance Withdrawal Syndrome; Time Factors; Verapamil | 1986 |
[Myocardial infarction after abrupt withdrawal of a calcium inhibitor].
Topics: Aged; Benzazepines; Diltiazem; Female; Humans; Myocardial Infarction; Substance Withdrawal Syndrome | 1986 |
Diltiazem withdrawal syndrome: an opposing viewpoint.
Topics: Angina Pectoris, Variant; Diltiazem; Humans; Myocardial Infarction; Substance Withdrawal Syndrome | 1987 |
Myocardial infarction with normal results of coronary angiography following diltiazem withdrawal.
Topics: Adult; Angiography; Benzazepines; Calcium; Diltiazem; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Myocardial Infarction; Substance Withdrawal Syndrome; Uremia | 1986 |